Lv1
20 积分 2023-05-21 加入
A disease‐specific quality of life instrument for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: CLDQ‐NAFLD
8小时前
待确认
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease
1天前
已完结
Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
1天前
已完结
Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease
1天前
已完结
The Harvard Medical School Pathways curriculum: A comprehensive curricular evaluation
3个月前
已完结
Serum IGF-1 In the Diagnosis of Acromegaly and the Profile of Patients with Elevated IGF-1 but Normal Glucose-Suppressed Growth Hormone
6个月前
已完结
Effective Long-Term Treatment of Cushing’s Disease with Pasireotide: A Case Report
6个月前
已完结
CUSHING'S SYNDROME?KILLING DISEASE: DISCRIMINATORY VALUE OF SIGNS AND SYMPTOMS AIDING EARLY DIAGNOSIS
6个月前
已完结
Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation
6个月前
已关闭
Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study
6个月前
已完结
皖公网安备34019202002308
